Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19.
Margaux LafaurieGuillaume Martin-BlondelPierre DelobelNassim KamarSandrine CharpentierAgnès SommetGuillaume Moulisnull nullPublished in: BMC pharmacology & toxicology (2021)
Overall, this study provide some evidences for an absence of an increased risk of unfavorable outcome with previous exposure to corticosteroids in the general setting of patients hospitalized for COVID-19.